Bayer AG
XETRA:BAYN
Bayer AG
Net Income
Bayer AG
Net Income Peer Comparison
Competitive Net Income Analysis
Latest Figures & CAGR of Competitors
Company | Net Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bayer AG
XETRA:BAYN
|
Net Income
-€2.9B
|
CAGR 3-Years
43%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Net Income
-$43.9m
|
CAGR 3-Years
37%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck KGaA
XETRA:MRK
|
Net Income
€2.8B
|
CAGR 3-Years
12%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
9%
|
|
MPH Health Care AG
XETRA:93M1
|
Net Income
€29.1m
|
CAGR 3-Years
38%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
Dermapharm Holding SE
XETRA:DMP
|
Net Income
€106m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Net Income
€12m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
See Also
What is Bayer AG's Net Income?
Net Income
-2.9B
EUR
Based on the financial report for Dec 31, 2023, Bayer AG's Net Income amounts to -2.9B EUR.
What is Bayer AG's Net Income growth rate?
Net Income CAGR 3Y
43%
The average annual Net Income growth rates for Bayer AG have been 43% over the past three years .